X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5302) 5302
Publication (448) 448
Newsletter (152) 152
Book Review (39) 39
Newspaper Article (35) 35
Book Chapter (29) 29
Magazine Article (25) 25
Book / eBook (8) 8
Conference Proceeding (6) 6
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4340) 4340
male (2102) 2102
polycythemia-vera (2100) 2100
female (2039) 2039
hematology (2019) 2019
index medicus (1951) 1951
middle aged (1838) 1838
essential thrombocythemia (1569) 1569
aged (1517) 1517
adult (1345) 1345
polycythemia vera (1171) 1171
oncology (1070) 1070
mutation (975) 975
janus kinase 2 - genetics (854) 854
polycythemia (850) 850
myelofibrosis (849) 849
myeloproliferative disorders (816) 816
polycythemia vera - drug therapy (783) 783
polycythemia vera - therapy (747) 747
polycythemia vera - complications (740) 740
aged, 80 and over (636) 636
myeloproliferative neoplasms (595) 595
tyrosine kinase jak2 (544) 544
leukemia (538) 538
hydroxyurea (501) 501
thrombosis (501) 501
polycythemia vera - genetics (470) 470
risk factors (468) 468
polycythemia vera - diagnosis (459) 459
diagnosis (432) 432
jak2 (427) 427
care and treatment (412) 412
myeloproliferative disorders - genetics (400) 400
animals (396) 396
prognosis (389) 389
primary myelofibrosis (383) 383
hydroxyurea - therapeutic use (381) 381
therapy (366) 366
treatment outcome (361) 361
medicine, general & internal (359) 359
myeloid metaplasia (358) 358
tumors (356) 356
research (354) 354
polycythemia vera - blood (352) 352
adolescent (335) 335
genetic aspects (326) 326
polycythemia vera - pathology (321) 321
thrombocythemia, essential - drug therapy (305) 305
antineoplastic agents - therapeutic use (295) 295
thrombocythemia, essential - genetics (294) 294
analysis (292) 292
hemic and lymphatic diseases (292) 292
primary myelofibrosis - genetics (285) 285
retrospective studies (277) 277
medicine & public health (276) 276
follow-up studies (259) 259
cancer (256) 256
hematocrit (256) 256
janus kinase 2 - antagonists & inhibitors (256) 256
disorders (254) 254
primary myelofibrosis - drug therapy (251) 251
myeloproliferative disorders - drug therapy (250) 250
disease (243) 243
janus kinase 2 (241) 241
thrombocythemia, essential - complications (238) 238
chronic myeloproliferative disorders (237) 237
health aspects (231) 231
ruxolitinib (227) 227
diagnosis, differential (226) 226
young adult (225) 225
bone marrow - pathology (219) 219
myeloproliferative disorders - diagnosis (219) 219
risk (217) 217
acute myeloid-leukemia (214) 214
international working group (212) 212
janus kinase 2 - metabolism (212) 212
hematology, oncology and palliative medicine (211) 211
article (209) 209
bone marrow (208) 208
platelet count (207) 207
mice (205) 205
thrombosis - etiology (203) 203
primary myelofibrosis - pathology (202) 202
abridged index medicus (201) 201
thrombocythemia, essential - diagnosis (200) 200
phlebotomy (196) 196
chronic myelogenous leukemia (193) 193
survival (191) 191
idiopathic myelofibrosis (187) 187
jak2 v617f mutation (185) 185
myeloproliferative disorders - pathology (185) 185
chronic myeloid-leukemia (184) 184
patients (184) 184
child (181) 181
disease progression (181) 181
management (181) 181
hydroxyurea - adverse effects (179) 179
blood (178) 178
primary myelofibrosis - diagnosis (176) 176
medical research (175) 175
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4905) 4905
German (151) 151
French (121) 121
Russian (110) 110
Japanese (66) 66
Italian (32) 32
Polish (31) 31
Spanish (27) 27
Hungarian (23) 23
Danish (15) 15
Chinese (9) 9
Czech (8) 8
Dutch (8) 8
Korean (8) 8
Romanian (7) 7
Hebrew (6) 6
Turkish (4) 4
Finnish (3) 3
Serbian (3) 3
Swedish (3) 3
Norwegian (2) 2
Slovak (2) 2
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 22 - 33
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2013, Volume 88, Issue 6, pp. 507 - 516
Disease Overview Polycythemia Vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPN) primarily characterized by erythrocytosis and... 
Thrombocytosis - blood | Humans | Risk Factors | Polycythemia Vera - blood | Survival Analysis | Polycythemia Vera - therapy | Polycythemia Vera - diagnosis | Thrombocytosis - therapy | Thrombocytosis - diagnosis | Aspirin | Erythropoietin | Anemia | Polycythemia | Leukemia | Development and progression | Hydroxyurea | Diagnosis | Biological response modifiers | Risk factors
Journal Article
Journal Article
Journal Article
Vnitrni lekarstvi, ISSN 0042-773X, 09/2018, Volume 64, Issue 10, pp. 955 - 960
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 09/2018, Volume 16, Issue 9, pp. 587 - 589
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 426 - 435
Journal Article